These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 26549027)

  • 1. Cytoplasmic PML promotes TGF-β-associated epithelial-mesenchymal transition and invasion in prostate cancer.
    Buczek ME; Miles AK; Green W; Johnson C; Boocock DJ; Pockley AG; Rees RC; Hulman G; van Schalkwyk G; Parkinson R; Hulman J; Powe DG; Regad T
    Oncogene; 2016 Jun; 35(26):3465-75. PubMed ID: 26549027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PMLIV overexpression promotes TGF-β-associated epithelial-mesenchymal transition and migration in MCF-7 cancer cells.
    Liu Y; Wang JX; Huang D; Wang B; Li LL; Li XX; Ni P; Dong XL; Xia W; Yu CX; Xu WL; Chu WF; Zhao D
    J Cell Physiol; 2018 Dec; 233(12):9575-9583. PubMed ID: 29943817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytoplasmic PML function in TGF-beta signalling.
    Lin HK; Bergmann S; Pandolfi PP
    Nature; 2004 Sep; 431(7005):205-11. PubMed ID: 15356634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Promyelocytic leukaemia protein and defect in transforming growth factor-beta signal pathway in acute promyelocytic leukaemia].
    Fuchs O; Provazníková D; Peslová G
    Cas Lek Cesk; 2005; 144(2):90-4. PubMed ID: 15807293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The metastasis suppressor CD82/KAI1 represses the TGF-β
    Lee MS; Lee J; Kim YM; Lee H
    Prostate; 2019 Sep; 79(12):1400-1411. PubMed ID: 31212375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasohibin-2 is required for epithelial-mesenchymal transition of ovarian cancer cells by modulating transforming growth factor-β signaling.
    Norita R; Suzuki Y; Furutani Y; Takahashi K; Yoshimatsu Y; Podyma-Inoue KA; Watabe T; Sato Y
    Cancer Sci; 2017 Mar; 108(3):419-426. PubMed ID: 28064471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor-β promotes aggressiveness and invasion of clear cell renal cell carcinoma.
    Sitaram RT; Mallikarjuna P; Landström M; Ljungberg B
    Oncotarget; 2016 Jun; 7(24):35917-35931. PubMed ID: 27166254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of In Vitro Model of Epithelial Mesenchymal Transition (EMT) Via the Expression of a Cytoplasmic Mutant Form of Promylocytic Leukemia Protein (PML).
    Di Biase A; Miles AK; Regad T
    Methods Mol Biol; 2018; 1692():129-138. PubMed ID: 28986893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An novel inhibitor of TGF-β type I receptor, IN-1130, blocks breast cancer lung metastasis through inhibition of epithelial-mesenchymal transition.
    Park CY; Min KN; Son JY; Park SY; Nam JS; Kim DK; Sheen YY
    Cancer Lett; 2014 Aug; 351(1):72-80. PubMed ID: 24887560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elf5 inhibits TGF-β-driven epithelial-mesenchymal transition in prostate cancer by repressing SMAD3 activation.
    Yao B; Zhao J; Li Y; Li H; Hu Z; Pan P; Zhang Y; Du E; Liu R; Xu Y
    Prostate; 2015 Jun; 75(8):872-82. PubMed ID: 25728398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TSC1 activates TGF-β-Smad2/3 signaling in growth arrest and epithelial-to-mesenchymal transition.
    Thien A; Prentzell MT; Holzwarth B; Kläsener K; Kuper I; Boehlke C; Sonntag AG; Ruf S; Maerz L; Nitschke R; Grellscheid SN; Reth M; Walz G; Baumeister R; Neumann-Haefelin E; Thedieck K
    Dev Cell; 2015 Mar; 32(5):617-30. PubMed ID: 25727005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dasatinib blocks transcriptional and promigratory responses to transforming growth factor-beta in pancreatic adenocarcinoma cells through inhibition of Smad signalling: implications for in vivo mode of action.
    Bartscht T; Rosien B; Rades D; Kaufmann R; Biersack H; Lehnert H; Gieseler F; Ungefroren H
    Mol Cancer; 2015 Nov; 14():199. PubMed ID: 26588899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. JAK/STAT3 signaling is required for TGF-β-induced epithelial-mesenchymal transition in lung cancer cells.
    Liu RY; Zeng Y; Lei Z; Wang L; Yang H; Liu Z; Zhao J; Zhang HT
    Int J Oncol; 2014 May; 44(5):1643-51. PubMed ID: 24573038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of phosphatase and tensin homologue increases transforming growth factor beta-mediated invasion with enhanced SMAD3 transcriptional activity.
    Hjelmeland AB; Hjelmeland MD; Shi Q; Hart JL; Bigner DD; Wang XF; Kontos CD; Rich JN
    Cancer Res; 2005 Dec; 65(24):11276-81. PubMed ID: 16357132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor-β-induced plasticity causes a migratory stemness phenotype in hepatocellular carcinoma.
    Malfettone A; Soukupova J; Bertran E; Crosas-Molist E; Lastra R; Fernando J; Koudelkova P; Rani B; Fabra Á; Serrano T; Ramos E; Mikulits W; Giannelli G; Fabregat I
    Cancer Lett; 2017 Apr; 392():39-50. PubMed ID: 28161507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. OSR1 phosphorylates the Smad2/3 linker region and induces TGF-β1 autocrine to promote EMT and metastasis in breast cancer.
    Li Y; Li L; Qin J; Wu J; Dai X; Xu J
    Oncogene; 2021 Jan; 40(1):68-84. PubMed ID: 33051597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ETS1 induces transforming growth factor β signaling and promotes epithelial-to-mesenchymal transition in prostate cancer cells.
    Rodgers JJ; McClure R; Epis MR; Cohen RJ; Leedman PJ; Harvey JM; ; Thomas MA; Bentel JM
    J Cell Biochem; 2019 Jan; 120(1):848-860. PubMed ID: 30161276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin inhibits the radiation-induced invasive phenotype of esophageal squamous cell carcinoma.
    Nakayama A; Ninomiya I; Harada S; Tsukada T; Okamoto K; Nakanuma S; Sakai S; Makino I; Kinoshita J; Hayashi H; Oyama K; Miyashita T; Tajima H; Takamura H; Fushida S; Ohta T
    Int J Oncol; 2016 Nov; 49(5):1890-1898. PubMed ID: 27599468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. APPL proteins promote TGFβ-induced nuclear transport of the TGFβ type I receptor intracellular domain.
    Song J; Mu Y; Li C; Bergh A; Miaczynska M; Heldin CH; Landström M
    Oncotarget; 2016 Jan; 7(1):279-92. PubMed ID: 26583432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The TGF-β signalling negative regulator PICK1 represses prostate cancer metastasis to bone.
    Dai Y; Ren D; Yang Q; Cui Y; Guo W; Lai Y; Du H; Lin C; Li J; Song L; Peng X
    Br J Cancer; 2017 Aug; 117(5):685-694. PubMed ID: 28697177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.